Precision Biosciences Inc (NASDAQ: DTIL) is 23.84% higher on its value in year-to-date trading and has touched a low of $8.25 and a high of $28.44 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DTIL stock was last observed hovering at around $12.98 in the last trading session, with the day’s gains setting it 0.58%.
Currently trading at $13.56, the stock is 9.57% and 10.89% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.19 million and changing 4.47% at the moment leaves the stock 2.88% off its SMA200. DTIL registered -41.09% loss for a year compared to 6-month gain of 22.16%. The firm has a 50-day simple moving average (SMA 50) of -$0.19 and a 200-day simple moving average (SMA200) of $0.13.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -26.94% loss in the last 1 month and extending the period to 3 months gives it a 25.17%, and is 13.38% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.92% over the week and 7.49% over the month.
Precision Biosciences Inc (DTIL) has around 109 employees, a market worth around $55.05M and $48.73M in sales. Profit margin for the company is -143.18%. Distance from 52-week low is 64.36% and -52.32% from its 52-week high. The company has generated returns on investments over the last 12 months (-262.43%).
Precision Biosciences Inc quarterly earnings per share for the current quarter are estimated at -$2.11 with sales reaching $7.47M over the same period.The EPS is expected to grow by 29.52% this year, but quarterly earnings will post -35.50% year-over-year.
82 institutions hold shares in Precision Biosciences Inc (DTIL), with institutional investors hold 47.88% of the company’s shares. The shares outstanding are 4.16M, and float is at 3.60M with Short Float at 4.95%. Institutions hold 43.46% of the Float.
The top institutional shareholder in the company is Great Point Partners LLC with over 7.47 million shares valued at $3.93 million. The investor’s holdings represent 6.49% of the DTIL Shares outstanding. As of Jun 29, 2023, the second largest holder is Capital World Investors with 6.72 million shares valued at $3.53 million to account for 5.84% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 4.72 million shares representing 4.10% and valued at over $2.48 million, while Acadian Asset Management. LLC holds 2.53% of the shares totaling 2.91 million with a market value of $1.53 million.
Precision Biosciences Inc (DTIL) Insider Activity
The most recent transaction is an insider sale by SMITH J. JEFFERSON, the company’s Chief Research Officer. SEC filings show that SMITH J. JEFFERSON sold 28,000 shares of the company’s common stock on Jan 23 ’24 at a price of $0.37 per share for a total of $10360.0. Following the sale, the insider now owns 1.99 million shares.
Precision Biosciences Inc disclosed in a document filed with the SEC on Jan 22 ’24 that Amoroso Michael (President and CEO) sold a total of 137,390 shares of the company’s common stock. The trade occurred on Jan 22 ’24 and was made at $0.36 per share for $49460.0. Following the transaction, the insider now directly holds 0.36 million shares of the DTIL stock.
Still, SEC filings show that on Jan 22 ’24, List Alan (Chief Medical Officer) disposed off 21,526 shares at an average price of $0.36 for $7749.0. The insider now directly holds 94,982 shares of Precision Biosciences Inc (DTIL).
